According to the announcement Delphi and Milan's potential allocations requires shareholder approval in a meeting of members to be held late December. This is Tranch 2 of the funding per the company's recent presentation regarding this CR.
I can't imagine any of the other major shareholders voting against this as it will secure Wiluna's position as it transitions to stage 1 with extra $$$millions in the bank. ($17.85M)
Tranch 2 also involves our chair, my thoughts are that the majors will likely accept Milan buying in also as it means more skin in the game from insiders. I do like the fact that Milan seems to be backing every substantial raise we have had. It has not been short change either, this lot is $350k alone. Would be good to know how much he has invested over the years as the majority of his holdings has come from CR's and not free performance allocations which is a positive.
Add to My Watchlist
What is My Watchlist?